Urinary angiotensinogen as a novel mortality predictor in diabetic kidney disease: a propensity-matched analysis from

Sang Heon Suh1,2, Dohyeon Lee3, Hong Sang Choi1,2

  • 1Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.

Insights

Urinary angiotensinogen (UAGT/Cr) predicts mortality in diabetic kidney disease (DKD) patients but not in those without diabetes. This finding highlights UAGT/Cr as a potential biomarker for stratifying mortality risk in DKD.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiovascular Research

Background:

  • Diabetic kidney disease (DKD) significantly increases mortality risk.
  • Current biomarkers lack precision for stratifying mortality risk in DKD.
  • Intrarenal renin-angiotensin-aldosterone system (RAAS) activity is implicated in DKD progression.

Purpose of the Study:

  • To investigate urinary angiotensinogen (UAGT) as a predictor of all-cause mortality in chronic kidney disease (CKD) patients with and without diabetes.
  • To determine if UAGT reflects intrarenal RAAS activity and its association with mortality risk.
  • To assess the utility of UAGT/Cr for risk stratification in DKD.

Main Methods:

  • Prospective cohort study of 824 propensity score-matched CKD patients (412 with diabetes, 412 without).
  • Baseline urinary angiotensinogen-to-creatinine ratio (UAGT/Cr) categorized into quintiles.
  • Cox proportional hazards models used to estimate adjusted hazard ratios (HRs) for all-cause mortality.

Main Results:

  • UAGT/Cr independently predicted all-cause mortality in diabetic CKD patients (highest quintile HR 3.61, P < .001).
  • A monotonic relationship was observed between UAGT/Cr and mortality in diabetic patients.
  • No significant association between UAGT/Cr and mortality was found in non-diabetic CKD patients (P for interaction < .001).

Conclusions:

  • Urinary angiotensinogen-to-creatinine ratio (UAGT/Cr) is an independent predictor of all-cause mortality specifically in CKD patients with diabetes.
  • UAGT/Cr shows potential as an etiology-specific prognostic biomarker for risk stratification in diabetic kidney disease.
  • Findings suggest intrarenal RAAS activity, reflected by UAGT/Cr, plays a critical role in DKD mortality.
Abstract

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...